Solid-phase Synthesis of [4.4] Spirocyclic Oximes
February 6th, 2019
Here we present a protocol to demonstrate an efficient method for the synthesis of spirocyclic heterocycles. The five-step process utilizes solid-phase synthesis and regenerating Michael linker strategies. Generally difficult to synthesize, we present a customizable method for the synthesis of spirocyclic molecules otherwise inaccessible to other modern approaches.
This solid-phase organic synthetic technique may find applications in the construction of a combinatorial library, while synthesis of het spirocyclic heterocycles, which can be tested for anti-cancer activities using bioassays. Though this method can be used for the synthesis of spirocyclic compounds, it can also be applied to other small molecules, such as isoxazolines and isoxazoles. To begin the synthesis, add to a 25 millileter solid-phase reaction vessel one gram of REM resin, 20 millileters of dimethylformamide, and 2.4 milliliters of furfurylamine.
Cap the vessel and agitate it for 24 hours on a shaker at room temperature to load the resin with furfurylamine. Then drain the furfurylamine bearing resin and agitate it for about three minutes in five milliliters of DMF to wash it. After that, wash the resin four times, alternating between five milliliters of dichloromethane to swell the resin, and five milliliters of methanol to contract the resin.
Then thoroughly dry the resin with compressed air, which usually takes about 30 minutes. Next, in a well ventilated fume hood, add 1.48 milliliters of triethylamine, 10 milliliters of anhydrous toluene, and 637 grams of beta nitrostyrene to the dry furfurylamine bearing resin. Add one milliliter of trimethylsilyl chloride to the reaction mixture.
And leave the vessel open until the mixture has finished releasing hydrochloride gas. Then cap the vessel and agitate the mixture for 48 hours at room temperature to form the isoxazole intermediate. After that, add five milliliters of methanol to quench the reaction.
Shake the mixture for three minutes, and then let it soak for two minutes. Then drain the resin and wash it four times, alternating between five milliliters of DCM, and five milliliters of methanol. Thoroughly dry the washed resin with compressed air.
Next, add one milliliter of anhydrous tetrahydrofuran to the dry resin. Then add 1.24 milliliters of a one molar solution of tetra-n-butylammonium flouride in the THF and agitate the mixture at room temperature for 12 hours to open the isoxazole ring. Afterward, strain the resin and wash it with five milliliters of THF, followed by four washes alternating between five milliliters of DCM and five milliliters of methanol.
Dry the resin thoroughly with compressed air. Next, add five milliliters of DMF to the resin, followed by one milliliter of one-bromooctane. Agitate the mixture for 24 hours at room temperature to form the quaternary amine.
Then drain the resin and wash it with five milliliters of DMF. Wash the resin four more times, alternating between DCM and methanol, and dry with compressed air. Next, add three milliliters of DCM to the dry resin, followed by 1.5 milliliters of TEA.
Agitate the mixture for 24 hours to cleave the spirocyclic oxime from the polymer support. Then, collect the crude product in a vial or flask. Wash the resin four times, alternating between DCM and methanol, and collect the washes in the product vial.
Remove volatiles from the product mixture on a rotary evaporator. Then, triturate the crude product with 5 milliliters of boiling methanol, and carefully remove the liquid. Wash the resin twice with five milliliter portions of DCM and dry it with compressed air for reuse in subsequent experiments.
Spirocyclic oximes with various substituents were synthesized with excellent stereoselectivity. The overall yield indicates an average of 80 to 88%yield for each synthetic step. The reaction progress up through the isoxazole ring opening can be monitored by IR spectroscopy.
Generally, individuals new to this method struggle with selecting the appropriate polymer support linker. It is essential for the linker to be robust to all reaction conditions during the synthesis. While attempting this procedure, remember to wash and dry the resin before the next reaction step.
Leftover reagents from the previous step will complicate the overall synthesis and will affect the yield and purity of the spirocyclic product.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a solid-phase organic synthetic technique for the efficient synthesis of spirocyclic heterocycles. The method involves a five-step process utilizing regenerating Michael linker strategies, making it customizable for various spirocyclic molecules.
Key Study Components
Area of Science
- Organic Chemistry
- Synthetic Methods
- Pharmaceutical Applications
Background
- Spirocyclic compounds are generally difficult to synthesize.
- These compounds can be tested for anti-cancer activities.
- The method can also be applied to other small molecules.
- Solid-phase synthesis allows for efficient compound generation.
Purpose of Study
- To demonstrate a customizable method for synthesizing spirocyclic heterocycles.
- To provide a protocol that can be used in combinatorial library construction.
- To explore the potential applications of synthesized compounds in bioassays.
Methods Used
- Loading REM resin with furfurylamine in a solid-phase reaction vessel.
- Agitating the resin for 24 hours at room temperature.
- Washing the resin with DMF and alternating solvents.
- Employing a five-step synthesis process for spirocyclic compounds.
Main Results
- The method successfully synthesizes spirocyclic heterocycles.
- Demonstrated efficiency in generating compounds otherwise inaccessible.
- Potential applications in anti-cancer drug development.
- Versatility for synthesizing other small molecules like isoxazolines.
Conclusions
- This protocol provides a valuable tool for organic synthesis.
- It opens avenues for further research in medicinal chemistry.
- The method's efficiency could enhance drug discovery processes.
Frequently Asked Questions
Executive Industry Relevance
This solid-phase synthesis method enables efficient construction of spirocyclic heterocycles, which are valuable scaffolds in medicinal chemistry due to their structural rigidity and potential bioactivity. The approach supports combinatorial library generation for early-stage target validation and phenotypic screening campaigns. By providing high-yield, traceless product release and resin reusability, it reduces synthesis timelines and costs in hit-to-lead optimization workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables rapid generation of structurally diverse spirocyclic compounds for probing biological targets and pathway modulation.
- Operational Value: Supports hit identification through accessible synthesis of complex heterocycles that may be difficult to produce via solution-phase methods.
Screening & Assay Development
- Scientific Value: Produces pure, quantifiable compounds suitable for biochemical and cell-based assays targeting oncogenic pathways.
- Operational Value: Facilitates assay standardization via consistent compound quality and straightforward purification through filtration.
Translational & Preclinical Research
- Scientific Value: Enables exploration of structure-activity relationships in spirocyclic systems relevant to anticancer drug discovery.
- Operational Value: Supports preclinical progression by delivering compounds with defined stereochemistry and high diastereoselectivity.
Pipeline & Workflow Integration
The method fits within early discovery workflows, supporting lead identification through library synthesis and enabling progression to preclinical evaluation via reliable compound production.
- Discovery Biology: Supports hypothesis testing by generating diverse spirocyclic scaffolds for target engagement studies.
- Screening: Delivers assay-ready compounds with high purity and yield, enabling reliable dose-response profiling.
- Analytics: Allows reaction monitoring via IR spectroscopy, providing real-time feedback on synthesis progression.
- Translational Research: Produces compounds with anticancer potential that can be evaluated in disease-relevant models.
- Enterprise Reuse: Features a regenerating Michael linker system that allows multiple cycles of use, enhancing cost efficiency across projects.
Operational & Enterprise Impact
- Scientific Value: Enables access to stereodefined spirocyclic oximes with high diastereoselectivity, improving target confidence.
- Operational Value: Offers high yields (80–88% per step), simple filtration-based purification, and solvent compatibility for scalable execution.
- Strategic Value: Reduces attrition risk by providing reliable access to complex heterocycles for SAR exploration.
- Portfolio Impact: Supports risk-adjusted prioritization through rapid, reproducible analog generation.
Implementation Considerations
- Requires expertise in solid-phase organic synthesis and linker chemistry.
- Needs standard solid-phase reaction vessels, shakers, and compressed air for drying.
- Demands consistent washing and drying protocols between steps to prevent cross-contamination.
- Relies on IR spectroscopy for reaction monitoring due to solid-support limitations on NMR analysis.
- Performance depends on polymer/linker compatibility with multi-step reaction conditions involving bases, electrophiles, and fluoride sources.
![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg%3Fv%3D2026-07-04T08%253A08%253A27.000Z&w=384&q=75)
